News about Manufacturing

Co-Diagnostics? JV CoSara gets CDSCO clearance to manufacture & sell Saragene dengue and chikungunya RT-PCR tests

Co-Diagnostics? JV CoSara gets CDSCO clearance to manufacture & sell Saragene dengue and chikungunya RT-PCR tests

Co-Diagnostics, Inc., an US-based molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that CoSara Diagnostics Pvt Ltd (CoSara), its joint venture for manufacturing and sales in India

Manufacturing | 20/09/2021 | By Darshana

Moderna inks agreement with Resilience to manufacture mRNA for Covid-19 vaccine

Moderna inks agreement with Resilience to manufacture mRNA for Covid-19 vaccine

National Resilience, (Resilience), a company seeking to build the world?s most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna Covid-19 vaccine

Manufacturing | 13/09/2021 | By Darshana

Abbott acquires commercial-stage medical device company, Walk Vascular

Abbott acquires commercial-stage medical device company, Walk Vascular

Abbott, a global healthcare leader, announced that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product

Manufacturing | 03/09/2021 | By Darshana

Morepen Labs board approves transfer of POC medical devices business into wholly-owned subsidiary

Morepen Labs board approves transfer of POC medical devices business into wholly-owned subsidiary

Morepen Laboratories Ltd announced that the board has approved transfer of the point-of-care medical devices business into a wholly-owned subsidiary on a slump sale basis, which is expected to be completed on or before 31st March 2022, subject to receipt of requisite regulatory approvals and fulfillment of customary closing conditions

Manufacturing | 02/09/2021 | By Darshana

ASICS launches its new medical footwear range

ASICS launches its new medical footwear range

The newly launched footwear for medical professionals aims at meeting the fundamental functional requirements of medical and nursing care workplaces, combined with functionality of materials for athletic wear and cutting technologies permitting smoother body movement

Manufacturing | 02/09/2021 | By Darshana

Healthium acquires CareNow, strengthens R&D capabilities and portfolio

Healthium acquires CareNow, strengthens R&D capabilities and portfolio

Healthium, a global player in medical devices, announced the acquisition of CareNow Medical Private Limited, strengthening its product portfolio with patented and differentiated products in the advanced wound management and infection prevention segments

Manufacturing | 01/09/2021 | By Darshana

Dr Reddy?s and Zydus Pharma recall products in US market

Dr Reddy?s and Zydus Pharma recall products in US market

Dr Reddy?s Laboratories and Zydus Pharma are recalling bottles of a product each, in the US market, for different reasons, according to the latest report of the US health regulator. Dr Reddy?s Laboratories is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg, the latest enforcement report by the US Food and Drug Administration (USFDA) said

Manufacturing | 30/08/2021 | By Darshana

DCGI approves Zydus Cadila's three-dose Covid-19 vaccine for Emergency Use

DCGI approves Zydus Cadila's three-dose Covid-19 vaccine for Emergency Use

Zydus Cadila has received approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D on Friday

Manufacturing | 21/08/2021 | By Darshana

Indian pharma market registers 13.7% growth in July 2021

Indian pharma market registers 13.7% growth in July 2021

The Indian Pharmaceutical Market (IPM) has registered a growth of 13.7 per cent for the month of July 2021, after registering a growth of 14.1 per cent for the month of June 2021

Manufacturing | 18/08/2021 | By Darshana

Lupin receives US FDA tentative approval for generic Briviact tablets

Lupin receives US FDA tentative approval for generic Briviact tablets

Global pharma major Lupin Limited announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) brivaracetam tablets

Manufacturing | 17/08/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology